Table 1.
Variable* | Acute Period (hours 2–24, n=913) | Subacute Period (days 2–7, n=877) |
---|---|---|
Age | 62.1±13.1 | 61.9±12.9 |
Male | 563 (61.7) | 541 (61.7) |
Asian | 534 (58.4) | 539 (61.5) |
Glasgow Coma Score | 13.7±2.1 | 13.7±2.1 |
NIH Stroke Scale | 11.5±6.7 | 11.6±6.7 |
Intensive SBP control randomization arm | 452 (49.5) | 442 (50.4) |
Prior stroke | 147 (16.1) | 140 (16.0) |
Coronary artery disease | 40 (4.4) | 37 (4.2) |
Antihypertensive medication* | 448 (49.1) | 420 (47.9) |
Diabetic medication* | 132 (14.5) | 123 (14.0) |
Minutes from ICH onset to randomization | 184.0±56.8 | 182.5±56.2 |
Right-sided ICH** | 475 (52.0) | 455 (51.9) |
Lobar ICH** | 105 (11.5) | 95 (10.8) |
Intraventricular extension of ICH** | 244 (26.7) | 233 (26.6) |
ICH volume (mL)** | 15.1±14.8 | 15.2±14.3 |
Cerebral edema volume (mL)** | 2.8±3.7 | 2.8±3.6 |
Septum pellucidum shift (mm)** | 1.4±1.9 | 1.4±1.9 |
Number of blood pressure readings | 46±1 | 12±0 |
Systolic mean (mm Hg) | 140.2±13.5 | 144.0±10.8 |
Systolic SD (mm Hg) | 14.5±5.3 | 22.7±8.3 |
Systolic CV (mm Hg) | 10.3±3.6 | 15.8±5.8 |
Systolic ARV (mm Hg) | 13.9±6.7 | 26.0±11.4 |
Systolic SV (mm Hg) | 18.0±8.2 | 31.6±13.2 |
Systolic RSD (mm Hg) | 13.9±5.3 | 22.3±8.9 |
Continuous variables: mean±SD; categorical data: n(%).
Pre-morbid
Pre-randomization CT